These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Experimental characteristics of the spectrum of pharmacologic activity of the tranquilizer lorazepam]. Klygul' TA; Garibova TL; Vikhliaev IuI Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(3):435-8. PubMed ID: 235183 [No Abstract] [Full Text] [Related]
26. Behavioral effects of brotizolam, a new thienotriazolodiazepine derivative. Ueki S; Watanabe S; Yamamoto T; Shibata S; Shibata K Jpn J Pharmacol; 1984 Jul; 35(3):287-99. PubMed ID: 6541265 [TBL] [Abstract][Full Text] [Related]
27. [Contribution on the pharmacology of gamma-butyrolactone]. Hampel H; Hapke HJ Arch Int Pharmacodyn Ther; 1968 Feb; 171(2):306-22. PubMed ID: 5685835 [No Abstract] [Full Text] [Related]
28. Pharmacology of the central nervous system. Nelson SR; Walaszek EJ Prog Neurol Psychiatry; 1968; 23():134-54. PubMed ID: 4304825 [No Abstract] [Full Text] [Related]
29. [Effect of new pyrazolo-(1,2-a)-1,2,5-triazepine derivatives on the central nervous system]. Szadowska A; Mazur M; Kamińska A; Kusowska J; Winer A Acta Pol Pharm; 1982; 39(5-6):463-67. PubMed ID: 7171016 [No Abstract] [Full Text] [Related]
30. Anticonvulsant properties of some benzodiazepines. Swinyard EA; Castellion AW J Pharmacol Exp Ther; 1966 Mar; 151(3):369-75. PubMed ID: 5938475 [No Abstract] [Full Text] [Related]
31. Effects of some psychoactive drugs on experimental "neurotic" (conflict induced) behavior in cats. Yen HC; Krop S; Mendez HC; Katz MH Pharmacology; 1970; 3(1):32-40. PubMed ID: 5462431 [No Abstract] [Full Text] [Related]
32. 3-Halo-5,7-dimethylpyrazolo [1,5-a]pyrimidines, a nonbenzodiazepinoid class of antianxiety agents devoid of potentiation of central nervous system depressant effects of ethanol or barbiturates. Kirkpatrick WE; Okabe T; Hillyard IW; Robins RK; Dren AT; Novinson T J Med Chem; 1977 Mar; 20(3):386-93. PubMed ID: 15111 [TBL] [Abstract][Full Text] [Related]
33. [Neuropharmacologic study on the effect of nitrazepam on the central nervous system]. Yamamoto K; Sawada T; Naito Y; Kido R No To Shinkei; 1969 May; 21(5):488-502. PubMed ID: 4980684 [No Abstract] [Full Text] [Related]
35. Pharmacology and hypnogenic properties of brotizolam in animals. Kuhn FJ; Böke-Kuhn K; Danneberg P; Lehr E; Stockhaus K Br J Clin Pharmacol; 1983; 16 Suppl 2(Suppl 2):253S-260S. PubMed ID: 6140946 [TBL] [Abstract][Full Text] [Related]
36. [Modification of the alcohol effect by valepotriate]. von Eickstedt KW Arzneimittelforschung; 1969 Jun; 19(6):995-7. PubMed ID: 5820046 [No Abstract] [Full Text] [Related]
37. Pharmacological and neurochemical properties of 1,4-diazepines with two annelated heterocycles ('hetrazepines'). Weber KH; Kuhn FJ; Böke-Kuhn K; Lehr E; Danneberg PB; Hommer D; Paul SM; Skolnick P Eur J Pharmacol; 1985 Feb; 109(1):19-31. PubMed ID: 2986988 [TBL] [Abstract][Full Text] [Related]
38. Effects of opioid antagonists on anticonvulsant and hypnotic activity of benzodiazepines. Fidecka S; Langwiński R Pol J Pharmacol; 1996; 48(4):409-14. PubMed ID: 9112681 [TBL] [Abstract][Full Text] [Related]
39. Pharmacological investigations with benzoctamine (Tacitin), a new psycho-active agent. Baltzer V; Bein HJ Arch Int Pharmacodyn Ther; 1973 Jan; 201(1):25-41. PubMed ID: 4197881 [No Abstract] [Full Text] [Related]
40. [Behavioral effects of flutoprazepam (KB-509) and its metabolites]. Ueki S; Sukamoto T; Watanabe S; Yamamoto T; Kataoka Y; Shibata S; Suwandi D; Shibata K; Takano M; Sato Y Nihon Yakurigaku Zasshi; 1982 Jul; 80(1):15-30. PubMed ID: 6890927 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]